Daniel Ek isn't done disrupting industries. The Spotify founder's health tech startup Neko Health just closed a $700 million funding round and is bringing its AI-powered body-scanning clinics to America. The company plans to open its first US location in New York this year before rolling out nationwide, betting that preventive health screenings using custom-built medical equipment can catch diseases like skin cancer and heart disease before they become life-threatening.
Spotify founder Daniel Ek is making his next big bet on AI, and this time it's not about music streaming. His health tech startup Neko Health just raised $700 million from a star-studded group of celebrities, entrepreneurs, and investment firms, according to The Verge. The company is now setting its sights on the United States, planning to open its first clinic in New York later this year before expanding rapidly across the country.
Neko operates private clinics that offer full-body scans and blood tests using AI and custom-built medical equipment. The scans are designed to proactively screen customers for conditions including skin cancer, heart disease, and diabetes. It's a stark departure from Ek's music empire, but the approach is similar - use technology to democratize access and catch problems before they spiral out of control.
The $700 million raise is one of the largest health tech funding rounds this year, signaling serious investor appetite for AI-driven preventive medicine. While Neko hasn't disclosed its valuation or the full list of investors, the round reportedly includes backing from entertainment industry figures and Silicon Valley heavyweights. The company has been quietly building momentum in European markets, where it already operates several clinics.
Ek co-founded Neko with Hjalmar Nilsonne, and together they've built proprietary scanning technology that can examine the entire body in about 30 minutes. The AI algorithms analyze everything from skin abnormalities to cardiovascular markers, looking for early warning signs that traditional annual checkups might miss. The company claims its goal is to catch problems early, prevent disease, and help people live longer - essentially treating health like a software problem that needs constant monitoring and updates.
The US expansion puts Neko in direct competition with other preventive health startups like Forward Health and Prenuvo, which offer similar full-body MRI scans and AI-powered diagnostics. But Neko's backing from Ek - who successfully scaled Spotify to over 500 million users - gives it a significant advantage in brand recognition and operational expertise.
The timing couldn't be better. Healthcare costs in the US continue to climb while life expectancy has stagnated. Investors are pouring money into companies promising to shift the model from reactive treatment to proactive prevention. AI has become the buzzword du jour in healthcare, with everything from drug discovery to diagnostic imaging getting the machine learning treatment.
But Neko faces real challenges in the American market. Healthcare regulations are notoriously complex, and the company will need to navigate a patchwork of state licensing requirements and insurance reimbursement policies. The scans likely won't be covered by most insurance plans initially, meaning customers will need to pay out of pocket - potentially limiting access to wealthy early adopters.
There's also the question of clinical validation. While early disease detection sounds great in theory, critics argue that excessive screening can lead to false positives, unnecessary anxiety, and overtreatment. Neko will need to prove that its AI-powered approach actually improves health outcomes, not just generates mountains of data.
Still, the market opportunity is massive. Americans spent over $4 trillion on healthcare in 2023, with chronic diseases accounting for the bulk of that spending. If Neko can demonstrate that catching conditions like diabetes or heart disease years earlier leads to better outcomes and lower costs, it could reshape how we think about preventive care.
The New York clinic is just the beginning. According to the announcement, Neko plans rapid expansion across major US cities once it establishes its foothold. The company is hiring aggressively for roles in operations, clinical staff, and AI engineering as it prepares for the rollout.
Neko Health's $700 million war chest and Daniel Ek's track record make it a serious player in the preventive health space. But the real test will be whether Americans embrace paying for proactive body scans and whether the company can prove its AI-powered approach actually saves lives. If Neko succeeds, it could accelerate the shift from treating disease to preventing it - and potentially save the healthcare system billions in the process. For now, all eyes are on that first New York clinic and whether Ek can replicate his streaming success in the very different world of healthcare.
